Daniel Verina, NP, Mount Sinai Health System
Advertisement
Articles by Daniel Verina, NP, Mount Sinai Health System
Advertisement
Latest Updated Articles
Study Overview: COLUMBA and PLEIADESMay 13th 2020
Infusion-Related Adverse EventsMay 13th 2020
Medication Supplements Prior to IV AdministrationMay 13th 2020
Community Advice: SQ Formulation of DaratumumabMay 13th 2020
Real-World Experience With SQ Monoclonal AntibodiesMay 13th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC
2
Ivonescimab Plus Chemotherapy Sustains OS Benefit Across Western and Asian Patients in Pretreated EGFR-Mutated NSCLC
3
How Are Treatment Intensification and Sequencing Reshaping Care in Prostate Cancer and RCC
4
NMPA Accepts Toripalimab Plus Chemotherapy Application for Expanded Stage II-III NSCLC Use
5